Blebbistatin
CAS No. 674289-55-5
Blebbistatin ( (±)-Blebbistatin )
产品货号. M24685 CAS No. 674289-55-5
Blebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥356 | 有现货 |
|
5MG | ¥567 | 有现货 |
|
10MG | ¥1077 | 有现货 |
|
25MG | ¥1831 | 有现货 |
|
50MG | ¥3216 | 有现货 |
|
100MG | ¥4844 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Blebbistatin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Blebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing.
-
产品描述Blebbistatin is a selective non-muscle myosin II (NMII) inhibitor. It promotes directional migration of corneal endothelial cells (CECs) and accelerates wound healing. Furthermore it preserves cell junctional integrity and barrier function.
-
同义词(±)-Blebbistatin
-
通路Endocrinology/Hormones
-
靶点ATPase
-
受体non-muscle myosin II ATPases
-
研究领域——
-
适应症——
化学信息
-
CAS Number674289-55-5
-
分子量292.3
-
分子式C18H16N2O2
-
纯度>98% (HPLC)
-
溶解度DMSO : 23 mg/mL (78.67 mM; Need ultrasonic)
-
SMILESCc(cc1)cc(C(C2(CC3)O)=O)c1N=C2N3c1ccccc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ho WT, et al. Targeting non-muscle myosin II promotes corneal endothelial migration through regulating lamellipodial dynamics. J Mol Med (Berl). 2019 Sep;97(9):1345-1357.
产品手册
关联产品
-
Esomeprazole Magnesi...
Esomeprazole Magnesium is a proton pump inhibitor to reduce gastric acid secretion.
-
(-)-Hydroxycitric ac...
(-)-Hydroxycitric acid (Garcinia acid) is the principal acid of fruit rinds of Garcinia cambogia. It is a potent and competitive inhibitor of ATP citrate lyase. (-)-Hydroxycitric acid suppresses fatty acid synthesis, food intake, lipogenesis, and induced weight loss.
-
BTB06584
BTB06584 is a novel acetohydroxyacid synthase(AHAS) inhibitor, a promising drug target against Mycobacterium tuberculosis (MTB).